(Q33368415)

26 July 2017

1 reference

title

Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

1 reference

Satoru Kosugi

1

1 reference

26 July 2017

Masanori Matsumoto

2

1 reference

26 July 2017

Yasushi Ohtani

3

1 reference

26 July 2017

Hironori Take

4

1 reference

26 July 2017

Hiromichi Ishizashi

5

1 reference

26 July 2017

Yoshihiro Fujimura

6

1 reference

26 July 2017

Jun Kuyama

7

1 reference

26 July 2017

language of work or name

1 reference

1 June 2005

1 reference

International Journal of Hematology

26 July 2017

published in

1 reference

26 July 2017

volume

81

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

433-436

1 reference

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

26 July 2017

cites work

1 reference

12 December 2020

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

12 December 2020

Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura: a review

1 reference

12 December 2020

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

1 reference

12 December 2020

Ticlopidine-Associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity

1 reference

12 December 2020

Rituximab for idiopathic membranous nephropathy

1 reference

12 December 2020

Diffuse neurodeficits in intravascular lymphomatosis with ADAMTS13 inhibitor

1 reference

12 December 2020

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide

1 reference

12 December 2020

Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

1 reference

12 December 2020

Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura

1 reference

12 December 2020

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

12 December 2020

Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome relapse: frequency, pathogenesis, and meaning.

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.04187

1 reference

Dimensions Publication ID

26 July 2017

1037379383

0 references

1 reference